Rigel Pharmaceuticals Inc

RIGL · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

61 USD

Margin of Safety

+32.2 %

Rating

BEOBACHTEN

Rigel Pharmaceuticals develops and commercializes approved therapeutics in the field of hematology and rare diseases, with royalties, product revenues from its own specialty pharmaceuticals, and milestone payments from partnerships representing the central revenue sources.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.